As a reminder, we have made a few updates to the study submission platform for this newsletter.
Simply click this link to submit your study information. Feel free to bookmark the link and share with colleagues that are looking to promote their research study through this communication channel.
If you have questions about this process or research studies in general, please contact us at email@example.com.
We appreciate your patience as we transition to this new promotion process.
We are seeking male volunteers for a research study on tension headache and muscle physiology.
You may be eligible if you:
Research Volunteers needed for 1 year research study looking at your body’s response to dietary changes after completing free weight loss program.
The purpose of this study is to understand how shift work impacts heart health in women.
We are inviting women ages 18-40 who currently engage in shift work to complete two, in-person visits between 1-2 hours over approximately a 3-month period.
This study plans to learn more about how consuming a diet with foods typical to a Mediterranean Diet such as whole grains, fruits and vegetables in a Western-style diet compares to eating a typical Western-style diet. This study will look at how diet affects overall health including risk factors for heart disease, gut health and inflammation as well as underlying mechanisms linking whole food to health. Findings from this study will potentially inform effective dietary recommendations and interventions, thereby reducing chronic disease in humans.
You may qualify if you:
This study plans to learn more about the effects of a medication, semaglutide, on cardiovascular function, kidney function, and insulin sensitivity in adults with type 1 diabetes. This medication has been effective in reducing cardiovascular disease and diabetic kidney disease in adults with type 2 diabetes. This study aims to look at how well the medication works in type 1 diabetes. We will perform a randomized study to assess the effects of 8 months of once weekly subcutaneous semaglutide vs. once weekly placebo injections.
Research Admin Communications